Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alexander Storch

Showing results (111-120 of 301) with videos related to

Pageof 31
Sort By:
Parkinsonism & Related Disorders|May 27, 2009
Levodopa-induced striatal activation in Parkinson's disease: a functional MRI studyEduard Kraft, Wolfgang Loichinger, Michael Diepers, et al.
Fortschritte Der Neurologie-Psychiatrie|July 19, 2018
[Treatment of end-of-dose fluctuations: the need for an individualized approach]Paul Lingor, Joseph Claßen, Heinz Herbst, et al.
Parkinsonism & Related Disorders|July 5, 2005
High-dose treatment with pergolide in Parkinson's disease patients with motor fluctuations and dyskinesiasAlexander Storch, Claudia Trenkwalder, Christian Oehlwein, et al.
Journal of Parkinson'S Disease|June 4, 2016
Assessment of Nonmotor Fluctuations Using a Diary in Advanced Parkinson's diseaseChristiana Ossig, Daniel Sippel, Mareike Fauser, et al.
Journal of Parkinson'S Disease|February 23, 2017
Timing and Kinetics of Nonmotor Fluctuations in Advanced Parkinson's DiseaseChristiana Ossig, Daniel Sippel, Mareike Fauser, et al.
Neurochemistry International|January 13, 2006
Dopamine transporter-mediated cytotoxicity of 6-hydroxydopamine in vitro depends on expression of mutant alpha-synucleins related to Parkinson's diseaseVera Lehmensiek, Eva-Maria Tan, Stefan Liebau, et al.
Annals of Neurology|August 24, 2017
Reply to "Converse well-being of locked-in patients and caregivers"Elisa Aust, Katharina Linse, Wolfgang Rüger, et al.
Archives of Gerontology and Geriatrics|July 21, 2005
High doses of pergolide improve clinical global impression in advanced Parkinson's disease:- a preliminary open label studyGuy Arnold, Thomas Gasser, Alexander Storch, et al.
Parkinsonism & Related Disorders|June 12, 2012
Immediate effects of deep brain stimulation of the subthalamic nucleus on nonmotor symptoms in Parkinson's diseaseMartin Wolz, Julia Hauschild, Jan Koy, et al.
Brain : a Journal of Neurology|July 5, 2023
Structural and molecular cholinergic imaging markers of cognitive decline in Parkinson's diseaseJulia Schumacher, Prabesh Kanel, Martin Dyrba, et al.
Pageof 31

Showing results (111-120 of 301) with videos related to

Sort By:
Pageof 31
Parkinsonism & Related Disorders|May 27, 2009
Levodopa-induced striatal activation in Parkinson's disease: a functional MRI studyEduard Kraft, Wolfgang Loichinger, Michael Diepers, et al.
Fortschritte Der Neurologie-Psychiatrie|July 19, 2018
[Treatment of end-of-dose fluctuations: the need for an individualized approach]Paul Lingor, Joseph Claßen, Heinz Herbst, et al.
Parkinsonism & Related Disorders|July 5, 2005
High-dose treatment with pergolide in Parkinson's disease patients with motor fluctuations and dyskinesiasAlexander Storch, Claudia Trenkwalder, Christian Oehlwein, et al.
Journal of Parkinson'S Disease|June 4, 2016
Assessment of Nonmotor Fluctuations Using a Diary in Advanced Parkinson's diseaseChristiana Ossig, Daniel Sippel, Mareike Fauser, et al.
Journal of Parkinson'S Disease|February 23, 2017
Timing and Kinetics of Nonmotor Fluctuations in Advanced Parkinson's DiseaseChristiana Ossig, Daniel Sippel, Mareike Fauser, et al.
Neurochemistry International|January 13, 2006
Dopamine transporter-mediated cytotoxicity of 6-hydroxydopamine in vitro depends on expression of mutant alpha-synucleins related to Parkinson's diseaseVera Lehmensiek, Eva-Maria Tan, Stefan Liebau, et al.
Annals of Neurology|August 24, 2017
Reply to "Converse well-being of locked-in patients and caregivers"Elisa Aust, Katharina Linse, Wolfgang Rüger, et al.
Archives of Gerontology and Geriatrics|July 21, 2005
High doses of pergolide improve clinical global impression in advanced Parkinson's disease:- a preliminary open label studyGuy Arnold, Thomas Gasser, Alexander Storch, et al.
Parkinsonism & Related Disorders|June 12, 2012
Immediate effects of deep brain stimulation of the subthalamic nucleus on nonmotor symptoms in Parkinson's diseaseMartin Wolz, Julia Hauschild, Jan Koy, et al.
Brain : a Journal of Neurology|July 5, 2023
Structural and molecular cholinergic imaging markers of cognitive decline in Parkinson's diseaseJulia Schumacher, Prabesh Kanel, Martin Dyrba, et al.
Pageof 31